R, P.; BASHIR, S. CRITICAL REVIEW OF PHARMACOGENOMICS IN ANTIPARKINSONIAN DRUG THERAPY: IMPACT ON CLINICAL MANAGEMENT OF PARKINSON’S DISEASE. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 9, n. 6, p. 24–27, 2016. DOI: 10.22159/ajpcr.2016.v9i6.13350. Disponível em: https://journals.innovareacademics.in/index.php/ajpcr/article/view/13350. Acesso em: 9 may. 2024.